Inhoudsopgave
Hoe lang werkt Trimbow?
Kinetische gegevens
| F | na inhalatie is ca. 13%; > 80% hiervan is afkomstig van absorptie in de longen. |
|---|---|
| T 1/2el | 5-12 uur (steady state bij COPD-patiënten). |
Wat is Trimbow aerosol?
De werkzame stoffen in Trimbow zijn beclometason, formoterol en glycopyrronium. Beclometason is sinds 1967 internationaal op de markt, formoterol sinds 1990 en glycopyrronium sinds 2013. Deze combinatie is op recept verkrijgbaar onder de merknaam Trimbow in inhalatiespray en inhalatiepoeder.
Wat zit er in Trimbow?
Waar wordt Foster voor gebruikt?
Foster
- Formoterol verwijdt vernauwde luchtwegen.
- Bij de longziekten astma en COPD (chronische obstructieve longziekte).
- De werking houdt 12 uur aan.
- U kunt het ook gebruiken om plotselinge benauwdheid op te heffen.
- Inhaleren is niet makkelijk.
- Er zijn verschillende inhalatie-apparaatjes.
What is formoterol used for?
Show More Formoterol is a long-acting bronchodilator used as a long-term (maintenance) treatment to prevent or decrease wheezing and trouble breathing caused by asthma or ongoing lung disease ( chronic obstructive pulmonary disease – COPD, which includes chronic bronchitis and emphysema ).
How to use formoterol fumarate solution for nebulization?
How to use Formoterol Fumarate Solution For Nebulization. Using a mouthpiece or face mask with the nebulizer, inhale the prescribed dose of medication into your lungs, usually twice daily (morning and evening) or as directed by your doctor. The two doses should be about 12 hours apart. Each treatment usually takes about 9 minutes.
Can formoterol cause breathing problems?
Formoterol Fumarate Capsule, With Inhalation Device. WARNINGS: Rarely, in patients treated for asthma, serious (sometimes fatal) asthma-related breathing problems have occurred with the use of long-acting inhaled beta agonists (such as salmeterol). Because formoterol is similar to salmeterol, it may also cause these problems.
Does formoterol fumarate affect blood glucose levels in patients with COPD?
Dose-ranging and PK/PD studies have shown that 20 micrograms of a nebulized formoterol fumarate inhalation solution was comparable to 12 micrograms of formoterol fumarate dry powder in patients with COPD [ 65c ]. The former transiently reduced the mean serum potassium concentration and increased the mean serum glucose in a dose-related manner.